In Massachusetts, GenePeeks, Inc. has a new President and Chief Commercial Officer, Matt Posard, who comes with over 25 years of experience at a variety of genomic and life sciences companies including Illumina, Inc., Trovagene, Inc. and Alere, Inc. His role at GenePeeks will be to head up commercialization of their computational genomics products and services. Their patented Virtual Progeny Analytics product takes the genetic makeup of two parents and computationally predicts what diseases or health issues their child will be at risk for, genetically speaking, before they even conceive a baby. Many parents want to know the risks before they conceive, especially for serious diseases, so they can be more prepared for the possibilities.
Latest article
Faux foie gras firm forms foodie panel
In Paris, cultivated meat startup Gourmey has formed what it claims is the culinary industry’s first-ever advisory board dedicated to cultivated meat.
The panel...
Celleste Bio secures $4.5 million for cell-cultured cocoa
In Israel, cell cultured cocoa startup Celleste Bio has raised $4.5 million in a seed funding round. The funds will boost the company's research...
Wrapped up: Origami inspires paperboard packaging solution
In Finland, researchers from VTT and Aalto University are applying origami, the ancient Japanese art of paper folding, to the plastics waste crisis.
Led...